Mangalam Drugs And Organics Board of Directors

Get the latest insights into the leadership at Mangalam Drugs And Organics. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Govardhan M DhootChairman & Managing Director
Brijmohan DhootWhole Time Director
Nidhi MundadaNon Executive Independent Director
Praveen SaxenaNon Executive Independent Director
Rakesh K MilwaniNon Independent & Non Executive Director
Shweta PatelCompany Secretary & Compliance Officer

Mangalam Drugs And Organics Share price

MANGALAM

28.3

0.10 (0.35%)
NSE
BSE
Last updated on 23 Apr, 2026 | 15:14 IST
Today's High

28.30

Today's Low

28.13

52 Week Low

22.80

52 Week High

95.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Mangalam Drugs And Organics FAQs

The board at Mangalam Drugs And Organics consists of experienced professionals, including Govardhan M Dhoot, Brijmohan Dhoot, and others, overseeing the company’s strategic and corporate governance.

Directors at Mangalam Drugs And Organics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Govardhan M Dhoot is the current chairman at Mangalam Drugs And Organics.

Executive directors at Mangalam Drugs And Organics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Mangalam Drugs And Organics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Mangalam Drugs And Organics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost